SEC 13F Intelligence

Logan Capital Management Inc / ABBV

Logan Capital Management Inc’s Abbvie Inc Position

Does Logan Capital Management Inc own Abbvie Inc (ABBV)? Not currently — the last reported position was 79.4K shares worth $18M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$18M
Q4 2025
Shares
79.4K
% of Portfolio
+0.76%
Quarters Held
28
position exited

Position History ABBV

Reported value by quarter
Q4 ’18: $12MQ4 ’18Q1 ’19: $10MQ2 ’19: $11MQ3 ’19: $11MQ4 ’19: $12MQ4 ’19Q1 ’20: $10MQ2 ’20: $11MQ3 ’20: $10MQ4 ’20: $11MQ4 ’20Q1 ’21: $11MQ2 ’21: $11MQ3 ’21: $12MQ4 ’21: $14MQ4 ’21Q1 ’22: $16MQ2 ’22: $14MQ3 ’22: $12MQ4 ’22: $19MQ4 ’22Q1 ’23: $18MQ2 ’23: $16MQ3 ’23: $18MQ4 ’23: $18MQ4 ’23Q1 ’24: $20MQ2 ’24: $19MQ4 ’24: $19MQ1 ’25: $24MQ1 ’25Q2 ’25: $17MQ3 ’25: $20MQ4 ’25: $18Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q4 202579.4K$18M+0.76%
Q3 202588.0K$20M+0.86%
Q2 202590.3K$17M+0.78%
Q1 2025114.1K$24M+1.09%
Q4 2024109.6K$19M+0.82%
Q2 2024110.3K$19M+0.82%
Q1 2024111.4K$20M+0.87%
Q4 2023117.5K$18M+0.85%
Q3 2023122.4K$18M+0.93%
Q2 2023115.7K$16M+0.75%
Q1 2023113.5K$18M+0.88%
Q4 2022118.1K$19M+0.98%
Q3 202288.3K$12M+0.71%
Q2 202288.5K$14M+0.78%
Q1 2022100.3K$16M+0.79%
Q4 2021105.7K$14M+0.62%
Q3 2021108.3K$12M+0.54%
Q2 2021101.5K$11M+0.53%
Q1 2021101.4K$11M+0.55%
Q4 2020101.3K$11M+0.54%
Q3 2020112.4K$10M+0.53%
Q2 2020117.0K$11M+0.66%
Q1 2020135.4K$10M+0.72%
Q4 2019139.6K$12M+0.68%
Q3 2019146.2K$11M+0.65%
Q2 2019146.8K$11M+0.63%
Q1 2019127.0K$10M+0.63%
Q4 2018125.8K$12M+0.92%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Logan Capital Management Inc’s full portfolio or all institutional holders of ABBV.